Literature DB >> 21233636

Maternal and infant outcomes with concurrent treatment of tuberculosis and HIV infection in pregnant women.

Patricia L Toro, Karen L Schneider, Rosalind J Carter, Elaine J Abrams, Wafaa M El-Sadr, Andrea A Howard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233636     DOI: 10.1097/QAI.0b013e318201e11d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  5 in total

Review 1.  Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy.

Authors:  Jennifer R Shiu; Alan Min; Tony K L Kiang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

2.  Tuberculosis Case Finding in HIV-Infected Pregnant Women in Kenya Reveals Poor Performance of Symptom Screening and Rapid Diagnostic Tests.

Authors:  Sylvia M LaCourse; Lisa M Cranmer; Daniel Matemo; John Kinuthia; Barbra A Richardson; Grace John-Stewart; David J Horne
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

Review 3.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps.

Authors:  Jyoti S Mathad; Amita Gupta
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

4.  Risk factors for loss to follow-up prior to ART initiation among patients enrolling in HIV care with CD4+ cell count ≥200 cells/μL in the multi-country MTCT-Plus Initiative.

Authors:  R Charon Gwynn; Ashraf Fawzy; Ida Viho; Yingfeng Wu; Elaine J Abrams; Denis Nash
Journal:  BMC Health Serv Res       Date:  2015-06-25       Impact factor: 2.655

5.  Examining family planning and adverse pregnancy outcomes for women with active tuberculosis disease: a systematic review.

Authors:  Yen Nguyen; Katherine C McNabb; Jason E Farley; Nicole Warren
Journal:  BMJ Open       Date:  2022-03-28       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.